Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > #$30 in one day

<< Previous

Bullboard Posts

Next >>

Comment by TeddyTenBagson Feb 18, 2021 4:33pm

234 Views

Post# 32601698

RE:#$30 in one day

No one is taking over anything here. WSB hasn't shown anyone anything, especially on this stock where no one is shorting it. There is no army. Only you going around trying to pump and dump on any psychedelics/weed stocks you can find.

It's sad.

maysteeler23 wrote: Wallstreetbets showed us the way. Our army will take the lead and where they failed we will succeed because our revolution will change society forever.

The sky is the limit. Together we are unstoppable.

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth